Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.3.1 (
alkaline phosphatase
)
47,916
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Osteoblast maturation is a multistep series of events characterized by an integrated cascade of gene expression that are accompanied by specific phenotypic alterations. To find new osteoblast-related genes we cloned differentially expressed cDNAs characteristic of specific differentiation stages in the mouse osteoblast-like MC3T3-E1 cells by a differential display method. We identified a novel cDNA encoding a putative glycerophosphodiester phosphodiesterase,
GDE3
, which specifically was expressed at the stage of matrix maturation. Interestingly, the deduced amino acid sequence contains 539 amino acids including seven putative transmembrane domains and a glycerophosphodiester phosphodiesterase region in one of the extracellular loops. Northern blot analysis revealed that
GDE3
was also expressed in spleen as well as primary calvarial osteoblasts and femur. We next transfected HEK293T cells with
GDE3
with green fluorescent protein fused to the C terminus. The green fluorescent protein-fused protein accumulated at the cell periphery, and the transfected cells overexpressing the protein changed from a spread form to rounded form with disappearance of actin filaments. Immunofluorescence staining with
GDE3
antibody and phalloidin in MC3T3-E1 cells indicated that endogenous
GDE3
might be co-localized with the actin cytoskeleton. To identify a role for
GDE3
in osteoblast differentiation, MC3T3-E1 cells stably expressing the full-length protein were constructed. Expression of
GDE3
showed morphological changes, resulting in dramatic increases in
alkaline phosphatase
activity and calcium deposit. These results suggest that
GDE3
might be a novel seven-transmembrane protein with a GP-PDE-like extracellular motif expressed during the osteoblast differentiation that dramatically accelerates the program of osteoblast differentiation and is involved in the morphological change of cells.
...
PMID:Novel membrane protein containing glycerophosphodiester phosphodiesterase motif is transiently expressed during osteoblast differentiation. 1293 6
The glycerophosphodiester phosphodiesterase enzyme family involved in the hydrolysis of glycerophosphodiesters has been characterized in bacteria and recently identified in mammals. Here, we have characterized the activity and function of
GDE3
, one of the seven mammalian enzymes.
GDE3
is up-regulated during osteoblast differentiation and can affect cell morphology. We show that
GDE3
is a glycerophosphoinositol (GroPIns) phosphodiesterase that hydrolyzes GroPIns, producing inositol 1-phosphate and glycerol, and thus suggesting specific roles for this enzyme in GroPIns metabolism. Substrate specificity analyses show that wild-type
GDE3
selectively hydrolyzes GroPIns over glycerophosphocholine, glycerophosphoethanolamine, and glycerophosphoserine. A single point mutation in the catalytic domain of
GDE3
(GDE3R231A) leads to loss of GroPIns enzymatic hydrolysis, identifying an arginine residue crucial for
GDE3
activity. After heterologous
GDE3
expression in HEK293T cells, phosphodiesterase activity is detected in the extracellular medium, with no effect on the intracellular GroPIns pool. Together with the millimolar concentrations of calcium required for
GDE3
activity, this predicts an enzyme topology with an extracellular catalytic domain. Interestingly,
GDE3
ectocellular activity is detected in a stable clone from a murine osteoblast cell line, further confirming the activity of
GDE3
in a more physiological context. Finally, overexpression of wild-type
GDE3
in osteoblasts promotes disassembly of actin stress fibers, decrease in growth rate, and increase in
alkaline phosphatase
activity and calcium content, indicating a role for
GDE3
in induction of differentiation. Thus, we have identified the
GDE3
substrate GroPIns as a candidate mediator for osteoblast proliferation, in line with the GroPIns activity observed previously in epithelial cells.
...
PMID:The developmentally regulated osteoblast phosphodiesterase GDE3 is glycerophosphoinositol-specific and modulates cell growth. 1959 59